leadf
logo-loader
viewEmerald Health Therapeutics Inc
(
CSE:EMHOTCQX:EMHTFFRA:TBD
)

Emerald Health Therapeutics channeling its efforts towards health and wellness segment of the market

Emerald Health Therapeutics Inc (CSE:EMH, OTCQX:EMHTF, FRA:TBD) (CSE:EMH) (OTCQX:EMHTF) CEO Riaz Bandali tells Proactive the Vancouver-Canada based medical cannabis grower is channeling its efforts towards the health and wellness segment of the market.

Bandali says this is 'a growing market segment, full of un-met needs' which he says, is largely ignored by other cannabis groups who are more focused on the adult-use cannabis market. Specifically, he says the group has launched a nano fast-acting spray, a sublingual tablet, which fall under the defined dose line of product, and in the last few weeks have launched a new beverage product focuses on the adult recreational market.

Quick facts: Emerald Health Therapeutics Inc

Follow
CSE:EMH

Price: 0.13 CAD

Market Cap: $27.73 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

Emerald Health Therapeutics predicts significant growth in Canadian cannabis...

Emerald Health Therapeutics Inc (CVE:EMH) (OTCQX:EMHTF) CEO Riaz Bandali talked with Proactive’s Steve Darling at the 12th annual LD Micro Conference. Vancouver-based Emerald Health is a licensed producer of cannabis. Its Verdélite operation in Quebec runs a 75,000 square feet indoor cannabis...

on 10/12/19

2 min read